Rizk, M. L. (2018). Intrapulmonary Pharmacokinetics of Relebactam, a Novel {beta}-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects [Pharmacology]. The American Society for Microbiology (ASM).
Chicago Style (17th ed.) CitationRizk, M. L. Intrapulmonary Pharmacokinetics of Relebactam, a Novel {beta}-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects [Pharmacology]. The American Society for Microbiology (ASM), 2018.
MLA (9th ed.) CitationRizk, M. L. Intrapulmonary Pharmacokinetics of Relebactam, a Novel {beta}-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects [Pharmacology]. The American Society for Microbiology (ASM), 2018.
Warning: These citations may not always be 100% accurate.